Kyowa Kirin Co., Ltd. (OTCMKTS:KYKOF) Sees Significant Decline in Short Interest

Kyowa Kirin Co., Ltd. (OTCMKTS:KYKOF) was the target of a large decrease in short interest in the month of January. As of January 15th, there was short interest totalling 422,100 shares, a decrease of 14.3% from the December 31st total of 492,300 shares. Based on an average daily volume of 200 shares, the days-to-cover ratio is presently 2,110.5 days.

Kyowa Kirin Price Performance

KYKOF remained flat at $14.80 during trading on Monday. Kyowa Kirin has a 52 week low of $13.28 and a 52 week high of $22.21. The company has a fifty day moving average price of $15.33 and a 200 day moving average price of $17.87.

Kyowa Kirin Company Profile

Kyowa Kirin Co, Ltd. engages in the research, development, manufacturing, marketing, and import/export of pharmaceuticals for oncology, nephrology, central nervous system, and immunology therapeutic areas in Japan, the United States, rest of the Americas, Europe, Asia, and internationally. Its products include ALLELOCK, an antihistamine agent for patients with various types of allergies; CONIEL, a calcium channel blocker for hypertension and angina pectoris; Crysvita, a recombinant human monoclonal IgG1 antibody against the phosphaturic hormone fibroblast growth factor 23; ESPO, a glycoprotein and human erythropoietin; NESP, an erythropoiesis stimulating agent; and GRAN, a human colony-stimulating factor.